The acting CDC director cited concerns with the methodology, but the design has long been used to test vaccine effectiveness.

Moderna (MRNA) ended the recent trading session at $51.30, demonstrating a -1.54% change from the preceding day's closing price. This change lagged the S&P 500's 0.62% gain on the day. Meanwhile, the ...

The new report found that healthy adults who received the Covid vaccine cut their risk of urgent care and emergency visits by 50 percent, and Covid-related hospitalizations by 55 percent, compared to ...

What happened next may become the most important medical story of the decade. In just six months, a team at Children’s ...

In just 69 minutes, Iran took advantage of a global network of accounts and media channels to spread its narrative around the ...

Novel approach to engineering complex microbial traits generates tens of millions of gene combinations, enabling gain-of-function traits beyond those observed from individual genes SAN DIEGO, April 8, ...

A specific protein controls mRNA transport in fungi and distinguishes important from unimportant binding sites in the ...

A new method of making cancer cells more visible to the immune system could improve how well immunotherapy works against a ...

Katalin Karikó, a Nobel Prize-winning scientist who pioneered mRNA research that led to life-saving vaccines during the COVID ...

A new single-cell technology is giving scientists their clearest view yet of immune cell behavior-capturing not just genetic intent but real-time activity.

A new method making cancer cells more visible to the immune system could improve how well immunotherapy works against a range of different tumours, potentially leading to more effective treatment for ...

CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...